Word abonnee en neem Beursduivel Premium
Rode planeet als pijlen grid met hoorntjes Beursduivel

BioPharma Terug naar discussie overzicht

SCON - geen biotech maar vergelijkbaar upside potentieel

30 Posts
Pagina: «« 1 2 | Laatste | Omlaag ↓
  1. [verwijderd] 20 juni 2015 11:16
    ik heb gister oktober calls toegevoegd.. sta op andere in de bid
    drop zonder nieuws en eerder zonder volume

    mogelijk russel index related nog.. mooi dan
    komende maanden is het do or die.. ik denk nog steeds do
  2. forum rang 10 DeZwarteRidder 20 juni 2015 11:32
    quote:

    crackedtooth schreef op 20 juni 2015 11:16:

    ik heb gister oktober calls toegevoegd.. sta op andere in de bid
    drop zonder nieuws en eerder zonder volume

    mogelijk russel index related nog.. mooi dan
    komende maanden is het do or die.. ik denk nog steeds do
    Hoeveel jaar denk je dat al....???
  3. gustaaf1e 15 juli 2015 21:50
    Wordt toch keurig op $1,- gehouden. Daar is vast een goede reden voor. En er is/zijn partij(en) die daar belang bij heeft/hebben.
    G
  4. [verwijderd] 20 juli 2015 17:29
    STI Advances Development With SFCL Customers
    AUSTIN, Texas, July 20, 2015 (GLOBE NEWSWIRE) -- Superconductor Technologies Inc. (STI) (Nasdaq:SCON), a world leader in the development and production of high temperature superconducting (HTS) materials and associated technologies, achieved positive results with multiple superconducting fault current limiter (SFCL) customers following the Conductus® wire evaluation and testing completed in June and July 2015. The SFCL results demonstrated dramatic improvement compared to tests completed earlier. In addition, STI successfully completed qualification testing with the Robinson Research Institute at Victoria University of Wellington. Conductus wire is now approved for use in making Roebel cable, a winding cable, which is used in high-field magnets, transformers, utility-scale generators and large motors.

    "As we rapidly approach final qualification, our customers are quickly providing detailed guidance that we believe will result in Conductus wire soon attaining all of the performance parameters required for SFCLs," stated Jeff Quiram, STI's president and chief executive officer. "We believe our SFCL customers have transitioned from a specification driven pass or fail testing methodology to a much more collaborative effort that involves business items such as forecasts, delivery lead times and price. Conductus wire is very close to passing all tests, and we are encouraged by our customers' confidence that our wire will be qualified in the next few months. In parallel, we have initiated business discussions to ensure product availability matches demand.

    "In conjunction with our partner, the Robinson Research Institute, we are engaged with multiple end use customers that plan to deploy Roebel cable in superconducting devices. With the successful qualification of Conductus for use in Robinson's Roebel cable, we believe we are well positioned to continue to aggressively pursue numerous opportunities in Asia."

    Test Description

    SFCL customers require Conductus wire to pass extensive engineering models and electrical testing that simulate characteristics of the wire performance in the SFCL device. The electrical tests replicate the thermal cycling of the superconducting wire in high-current operation. The latest results show that Conductus wire has made significant performance improvements in this area. Customers verified STI's 550 Amp current handling performance and recognized that the mechanical properties of Conductus provide unsurpassed robustness. The goal of SFCL manufacturers is to standardize on high performance wire that will ensure they have the best in class product to protect the grid in a majority of existing substation
  5. [verwijderd] 12 oktober 2015 16:01
    Weer wat geld aangetrokken. Laatste stuiptrekking.
    Koersverloop in overeenstemming met gang van zaken....helemaal niets.
    Rechtstreeks op weg naar pink sheets.

30 Posts
Pagina: «« 1 2 | Laatste |Omhoog ↑

Neem deel aan de discussie

Word nu gratis lid van Beursduivel.be

Al abonnee? Log in

Direct naar Forum

Zoek alfabetisch op forum

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
Forum # Topics # Posts
Aalberts 466 7.001
AB InBev 2 5.482
Abionyx Pharma 2 29
Ablynx 43 13.356
ABN AMRO 1.582 51.201
ABO-Group 1 22
Acacia Pharma 9 24.692
Accell Group 151 4.132
Accentis 2 264
Accsys Technologies 23 10.528
ACCSYS TECHNOLOGIES PLC 218 11.686
Ackermans & van Haaren 1 188
ADMA Biologics 1 34
Adomos 1 126
AdUX 2 457
Adyen 14 17.650
Aedifica 3 901
Aegon 3.258 322.664
AFC Ajax 538 7.086
Affimed NV 2 6.287
ageas 5.844 109.885
Agfa-Gevaert 14 2.048
Ahold 3.538 74.293
Air France - KLM 1.025 34.998
AIRBUS 1 11
Airspray 511 1.258
Akka Technologies 1 18
AkzoNobel 467 13.036
Alfen 16 24.333
Allfunds Group 4 1.468
Almunda Professionals (vh Novisource) 651 4.251
Alpha Pro Tech 1 17
Alphabet Inc. 1 405
Altice 106 51.198
Alumexx ((Voorheen Phelix (voorheen Inverko)) 8.486 114.813
AM 228 684
Amarin Corporation 1 133
Amerikaanse aandelen 3.835 242.741
AMG 971 133.088
AMS 3 73
Amsterdam Commodities 305 6.686
AMT Holding 199 7.047
Anavex Life Sciences Corp 2 485
Antonov 22.632 153.605
Aperam 92 14.936
Apollo Alternative Assets 1 17
Apple 5 380
Arcadis 252 8.731
Arcelor Mittal 2.033 320.578
Archos 1 1
Arcona Property Fund 1 286
arGEN-X 17 10.288
Aroundtown SA 1 219
Arrowhead Research 5 9.716
Ascencio 1 26
ASIT biotech 2 697
ASMI 4.108 39.082
ASML 1.766 106.061
ASR Nederland 21 4.451
ATAI Life Sciences 1 7
Atenor Group 1 470
Athlon Group 121 176
Atrium European Real Estate 2 199
Auplata 1 55
Avantium 32 13.610
Axsome Therapeutics 1 177
Azelis Group 1 64
Azerion 7 3.390

Macro & Bedrijfsagenda

  1. 07 februari

    1. Aperam Q4-cijfers
    2. Orange Belgium Q4-cijfers
    3. Crédit Agricole Q4-cijfers (Fra)
    4. TotalEnergies Q4-cijfers (Fra)
    5. Novo Nordisk Q4-cijfers (Dee)
    6. Industriële productie december (Dld)
    7. Handelsbalans december (Dld)
    8. Harley-Davidson Q4-cijfers (VS)
    9. Banengroei en werkloosheid januari (VS) Banengroei: 170K, werkloosheid: 4,1%, uurlonen: +3,8% YoY volitaliteit verwacht
    10. Consumentenvertrouwen (Universiteit v Michigan) februari vlpg (VS)
de volitaliteit verwacht indicator betekend: Market moving event/hoge(re) volatiliteit verwacht